Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.81% Nasdaq Up1.03%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.38 Up 0.02(1.10%) 12:12PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 323   323   324   323  
Cost of Revenue -   -   -   -  
Gross Profit 323   323   324   323  
Operating Expenses
Research Development11,889  19,414  16,203  20,962  
Selling General and Administrative4,499  4,440  7,324  12,449  
Non Recurring4  77  7,869  67  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (16,069) (23,608) (31,072) (33,155)
Income from Continuing Operations
Total Other Income/Expenses Net20  58  (16)(60)
Earnings Before Interest And Taxes(16,049)(23,550)(31,088)(33,215)
Interest Expense676  756  825  870  
Income Before Tax(16,725)(24,306)(31,913)(34,085)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(16,725)(24,306)(31,913)(34,085)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (16,725) (24,306) (31,913) (34,085)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (16,725) (24,306) (31,913) (34,085)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.